Human Jurkat lymphocytes clones differ in their capacity to support productive human immunodeficiency virus type 1

G Cervantes-Acosta1, E A Cohen, G Lemay

  • 1Département de Microbiologie et Immunologie, Université de Montréal, P.O. Box 6128, Station centre-ville, Québec, H3C 3J7, Montréal, Canada.

Insights

Jurkat cell clones vary in human immunodeficiency virus (HIV) replication support. Differences in syncytia formation and viral export highlight the need for careful cell line selection in HIV research.

Area of Science:

  • Virology
  • Cell Biology
  • Immunology

Background:

  • CD4-positive human lymphocytic cell lines are crucial for studying human immunodeficiency virus (HIV) replication.
  • Jurkat cells are frequently utilized for HIV research due to their CD4 expression.

Purpose of the Study:

  • To investigate the variability in HIV replication among different Jurkat cell clones and stocks.
  • To assess how these cellular differences impact key aspects of viral infection and multiplication.

Main Methods:

  • Utilized various Jurkat cell clones and stocks for HIV infection studies.
  • Analyzed parameters such as syncytia formation, Vpu-mediated viral export, and specific viral infectivity.

Main Results:

  • Significant variations observed in HIV replication efficiency across different Jurkat cell stocks.
  • Differences noted in syncytia formation, Vpu's effect on viral export, and the specific infectivity of released viruses.
  • Demonstrated substantial variability among independent cell stocks in supporting productive virus multiplication.

Conclusions:

  • The choice of specific Jurkat cell clones or stocks is critical for accurate HIV research.
  • Variability in cell lines underscores limitations of current tissue culture models for HIV studies.
  • Exploiting cellular differences offers potential for studying host-cell interactions in viral multiplication.